Learn about notable updates that occurred in June 2026 for investigational products in development (not an inclusive list).

Older adults with a new prescription for a sedative have an increased risk for falls and adverse events in the 30 days after ...

Initiating high-efficacy monoclonal antibody therapy before age 18 may reduce long-term disability in pediatric-onset multiple sclerosis.

Hypertension control among people experiencing homelessness can be improved through field-based health care programs.

High intake of ultra-processed foods is associated with an increased risk for cognitive impairment, particularly in adults younger than 60 years.